Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hormone Control of Calcium Metabolism ผศ.ดร.พญ.สุวัฒณี คุปติวฒ ุ ิ ภาควิชาสรีรวิทยา คณะแพทยศาสตรศิริราชพยาบาล Aims Calcium Homeostasis Hormone Control Calcium Metabolism Vitamin D PTH Calcitonin Other hormones Calcium and Phosphate function 1 Calcium homeostasis THE ONLY “IN” BONE DIETARY HABITS, SUPPLEMENTS BLOOD CALCIUM INTESTINAL ABSORPTION KIDNEYS URINE THE PRINCIPLE “OUT” Bone release Ca++ Kidney conserve Ca++ Ca++ is excreted in urine Bone incorporates Ca++ Intestine absorbs Ca++ Ca++ is excreted from diet 2 Parathyroid hormone (PTH) 84-amino acids polypeptide hormone PTH is released from the chief cells of the parathyroid gland. A decreased in plasma Ca2+mediates the release of PTH through calcium sensing receptor (CaSR). PTH binds to PTH/PTHrP receptor. 2nd messenger of PTH is cAMP (PKA pathway). Parathyroid glands 3 PTH actions (Kidney) Direct PTH increases Ca2+ reabsorption at the distal convoluted tubules (transcellular). PTH increases PO43 - and HCO3- excretion in the urine. PTH inhibit NPT2a at proximal tubule. PTH action (distal tubules) Ca2+ Paracellular (proximal tubule) Ca2+ PTH TrpV 5&6: epithelium calcium channels NCX: sodium/calcium exchanger 4 Proximal tubule Pi Pi PTH R NPT2a PTH NPT2a Pi PTH actions (Kidney) Indirect PTH 1-α hydroxylase 25 HCC 1,25 DHCC Intestinal absorption of Ca2+ 5 PTH actions (Bone) PTH acts on osteoblasts to inhibit the synthesis of collagen (inhibition of bone formation). PTH acts on osteoblasts to stimulate secretion of RANKL , which acts on the osteoclasts to promote demineralization and Ca2+release (osteoclastic bone resorption) RANKL: receptor activator of NF-kB ligand PTH actions (Bone) PTH also activates Ca2+pumps within the surface osteoblasts to move Ca2+out of bone fluid and into the extracellular fluid (ECF). [Ca2+] ×[PO43 - ] = คาคงที่ [Ca2+] [PO43 - ] [Ca2+] [PO43 - ] 6 Osteoblasts RANKL Osteoclast precursor cell Osteoclast PTH actions (Bone) PTH (basal level) Osteoblasts Bone formation Osteoclasts Bone resorption Bone remodeling 7 PTH actions Parathyroid glands Decrease blood Ca++ Bone releases Ca++ Increase blood Ca++ Kidney conserve Ca++ Increase active Vit D Intestine absorbs Ca++ Abnormal PTH secretion PTH deficit parathyroidectomy Hypocalcemia signs and symptoms PTH excess Primary hyperparathyroidism is the most common cause of hypercalcemia. The defect lies with the parathyroid tissue ex. adenoma Secondary hyperparathyroidism The defect is from other tissue such as chronic renal disease. Hypercalcemia signs and symptoms 8 Vitamin D synthesis SKIN LIVER 7-DEHYDROCHOLESTEROL VITAMIN D3 KIDNEY 25(OH)VITAMIN D 25-HYDROXYLASE 1α-HYDROXYLASE hν VITAMIN D3 25(OH)VITAMIN D (25-HCC) 1,25(OH)2 VITAMIN D (1,25-DHCC) (ACTIVE METABOLITE) TISSUE-SPECIFIC VITAMIN D RESPONSES 9 Vitamin D mechanism of action The action of Vit. D is mediated by altered gene transcription resulting in the synthesis of specific proteins. VIT D / VDR RNA POL Ex: CaBPs, Vitamin D3receptor 5’ UNTRANSLATED REGION VITAMIN D RESPONSIVE GENE TRANSCRIPTION START SITE IN THE NUCLEUS Vitamin D action GUT Ca2+ and PO4 3-absorption from the gut epithelium Ca2+ binding protein (CaBP) or by affecting 2+ Ca transport directly plasma membrane Ca2+ ATPase pump Ca2+ (PMCA) from enterocyte to blood BONE mineralization from blood Ca2+ to bone 10 Vitamin D action (enterocyte) Eletrochemical gradient Ca2+ Ca2+ Ca2+ Ca2+ TrpV 5 & 6 Ca2+ Ca2+ Ca2+ Ca2+ IMCal: Intestinal membrane calcium binding protein TrpV 5&6: epithelium calcium channels Vitamin D action KIDNEY tubular calcium reabsorption, possibly by the action of CaBP PARATHYROID Inhibit transcription of the PTH gene (feedback regulation) 11 Abnormal Vitamin D secretion Vitamin D deficit Uncalcified osteoid tissue Clinical syndromes broadly categorized as Rickets and Osteomalacia. Decreased blood calcium. Vitamin D excess Hypercalcemia (rare). Rickets / Osteomalacia 12 Calcium, PTH, and Vitamin D feedback loop BONE RESORPTION URINARY LOSS SUPPRESS PTH 1,25(OH)2 D PRODUCTION RISING BLOOD Ca2+ NORMAL BLOOD Ca2+ FALLING BLOOD Ca2+ BONE RESORPTION URINARY LOSS STIMULATE PTH 1,25(OH)2 D PRODUCTION Calcitonin 32 amino acids peptide. Calcitonin is released from parafollicular (C or clear cells) of the thyroid gland. Increased plasma Ca2+can stimulate calcitonin release. cAMP is the second messenger in the secretory process. 13 Parafollicular cells Calcitonin action The exact physiologic role of calcitonin is uncertain. BONE the osteclastic activity. KIDNEY Ca2+excretion in urine. 14 Calcium homeostasis Calcitonin Vit D THE ONLY “IN” BONE DIETARY HABITS, SUPPLEMENTS PTH BLOOD CALCIUM INTESTINAL ABSORPTION Calcitonin Active vitamin D PTH KIDNEYS Vit D PTH URINE THE PRINCIPLE “OUT” Other Hormones GH, IGFs Activate chondrocytes intestinal Ca2+absorption. renal PO43 – reabsorption. Thyroid hormone Physiological level: Increase bone formation. Excess: Increase bone resorption by decrease1,25 DHCC and increase renal Ca2+excretion. 15 Sex hormones Estrogen PTH action on bone Bone resorption Androgen PTH action on kidney Ca2+ excretion Bone formation Sex hormones Osteoporosis 16 Other Hormones Glucocorticoids GI Ca2+absorption. Renal Ca2+excretion. PTH. Osteoporosis Blood Calcium Function Structure of bone and teeth Hormone secretion and hormone action Neurotransmission Muscle contraction Blood Clotting 17 Blood Phosphate Function Structure of bone and teeth A covalent modifier of the activity of numerous enzymes. A component of many intermediates in glucose metabolism eg G-6-P. A component of all high energy transfer compounds eg ATP, NADP. Blood Calcium Blood calcium are tightly regulated at approximately 10 mg/dl. 18 Hypocalcemia: sign and symptoms NEUROMUSCULAR: CNS: IRRITABILITY, SEIZURES CARDIOVASCULAR: QT PROLONGATION INVOLUNTARY MUSCLE CONTRACTION (TETANY), 7TH CRANIAL NERVE EXCITABILITY (CHVOSTEK’S SIGN), NUMBNESS AND TINGLING IN FACE, HANDS, AND FEET, TROUSSEAU’S SIGN ON ECG Hypercalcemia: sign and symptoms CNS: lethargy, depression, decreased alertness, confusion, and coma GI: anorexia, constipation, nausea, and vomiting RENAL: diuresis, impaired concentrating ability, dehydration. Hypercalciuria is a risk for kidney stones. SKELETAL: most causes of hypercalcemia are associated with increased bone resorption, and thus, fracture risk CARDIOVASCULAR: shortened QT interval 19 Integrated regulation of calcium and phosphate Plasma calcium PTH secretion Plasma Phosphate Renal Phosphate 1,25 DHCC INTESTINAL ABSORPTION BONE RESORPTION Urine calcium Plasma calcium Plasma phosphate Urine phosphate Calcitonin secretion 20 Trousseau’s sign Chvostek’s sign 21 Ca2+ CaSR PTH PTH Gq +Gi - pro-PTH Down stream signaling pathway PTH gene prepro-PTH PTH mRNA Ca2+ Nucleus 1,251,25-Vit D CaSR PTH PTH Gq +Gi - pro-PTH Down stream signaling pathway prepro-PTH PTH mRNA - + PTH gene CaSR gene Nucleus 22